Home Top Movers Companies Concepts

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice

SCHEDULE 13G - Prelude Therapeutics Incorporated | StockGist | StockGist

Companies
PRLD
SCHEDULE 13G

Home Top Movers Companies Concepts

Home Filings PRLDSCHEDULE 13G

SCHEDULE 13G

Beneficial Ownership

Prelude Therapeutics Incorporated

Filed Nov 7, 2025

Accepted Nov 6, 2025, 7:00 PM ET

CIK 0001678660

View on SEC.gov Company Profile

Beneficial Ownership Report

Passive Investment

% of Class

9.99%

Reporting Person

Prelude Therapeutics Inc

Person Type

CO

CUSIP: 74065P101

Amendment History

5 filings

SCHEDULE 13G
Original
Viewing
Nov 7, 20250001104659-25-108459
SCHEDULE 13G/A
Amendment 1
Feb 13, 20250001193805-25-000177
SCHEDULE 13G/A
Amendment 2
Feb 14, 20250000929638-25-000784
SCHEDULE 13G/A
Amendment 3
May 15, 20250000929638-25-001925
SCHEDULE 13G/A
Amendment 4
Latest
Feb 13, 20260000929638-26-000626

Key Facts

% of Class

9.99%

Recent Filings

Prelude Therapeutics Incorporated3 weeks ago

Prelude Therapeutics Incorporated3 weeks ago

Prelude Therapeutics Incorporated3 weeks ago

Prelude Therapeutics Incorporated1 months ago

Prelude Therapeutics Incorporated2 months ago

Data Sources

Original SEC Filing SEC EDGAR Company Page

Market

Top Movers
Companies
Concepts

SEC Filings

AI Filing Analysis
Financial Reports
Current Reports
IPO Filings

Ownership

Institutional Holdings
Insider Trading

About

Data updates every 5 min
SEC EDGAR Source

© 2025–2026 StockGist|Information only, not investment advice